24 | TopicSem |
11 | De novo variants in exomes of congenital heart disease patients identify risk genes and pathways | J.Club | ||
23 | TopicSem |
25 | WES analysis of 25 patients with post ERCP pancreatitis | TopicSem |
27 | Study overview of post ERCP pancreatitis | xMutant |
14 | WES Analysis to search the risk factor of anthracycline-induced prolonged neutropenia | TopicSem | ||
14 | A coding variant in FTO related to thiopurine-induced leukopenia in East Asian | xMutant |
10 | Characteristic of pathogenic genes in ALL childhood patients with adverse reaction in L-asparaginase | TopicSem | ||
10 | WES analysis of AML samples according to neutropenia duration | MAInfo | ||
19 | Genotype-based Treatment With Thiopurine Reduces Incidence of Myelosuppression in Patients With Inflammatory Bowel Diseases | J.Club | ||
21 | Genomic analysis of L-asparaginase-induced pancreatitis in 25 Korean pediatric ALL patients. | Seminar | ||
26 | Genotype-based Treatment With Thiopurine Reduces Incidence of Myelosuppression in Patients With Inflammatory Bowel Diseases | J.Club |
19 | Analysis of genetic and clinical data in AML patients with prolonged neutropenia | xMutant |
10 | Analysis of candidate variants in patients with side effects of L-asparaginase | TopicSem |
29 | Analysis of candidate variants in patients with side effects of L-asparaginase | TopicSem |
11 | Analysis of candidate variants in patients with side effects of L-asparaginase | TopicSem |
26 | L-asparaginase induced acute pancreatitis in pediatric ALL patients | Seminar |
20 | WES analysis of AML samples according to neutropenia duration | xMutant | ||
29 | L-asparaginase induced acute pancreatitis in 26 pediatric ALL patients | TopicSem |
12 | WES analysis of AML samples according to neutropenia duration | xMutant | ||
14 | L-asparaginase associated acute pancreatitis in pediatric ALL patients | TopicSem |
07 | WES analysis of AML samples according to prolonged neutropenia duration | MAInfo | ||
14 | WES analysis of AML samples according to neutropenia duration | TopicSem |
07 | Lessons learned from additional research analyses of unsolved clinical exome cases | J.Club | ||
17 | WES analysis of AML samples according to prolonged neutropenia duration | xMutant |
26 | Modified workflow and statistical methods for AAP analysis | TopicSem |
12 | L-asparaginase associated acute pancreatitis in pediatric ALL patients | TopicSem | ||
14 | Analysis of AML exome sequencing | xMutant | ||
28 | Modified workflow and statistical methods for AAP analysis | MAInfo |
13 | L-asparaginase associated pancreatitis in pediatric ALL patients | TopicSem |
11 | Analysis of previously reported variants in pediatric ALL patients | TopicSem |
30 | Asparaginase-associated pancreatitis in pediatric ALL patients | TopicSem |
22 | WXS to detect genes causing Asparaginase-associated pancreatitis | TopicSem |
15 | WXS to detect genes causing AAP in 13 SNUH patients | TopicSem | ||
29 | WXS to detect genes causing AAP in 13 SNUH patients | MAInfo |
16 | WXS to detect genes causing AAP in 13 SNUH patients | TopicSem |
02 | Whole-exome sequencing to detect genes causing L-asparaginase-associated pancreatitis in 12 ALL patients | TopicSem | ||
12 | A pathway-centric approach to rare variant association analysis | J.Club |
12 | Localization of TCGA clinical data from GDC Data Portal | MAInfo | ||
26 | WXS to detect genes causing L-asparaginase induced pancreatitis | xMutant |
10 | Analysis of protein-coding genetic variation in 60,706 humans | J.Club | ||
19 | The human diseases network using genomic information | TopicSem |
17 | The summary of TCGA clinical data | MAInfo | ||
29 | Drug-induced pathways based on CMAP | xMutant |
04 | Drug-induced pathways based on CMAP | xMutant | ||
27 | The analysis for implicating sequence variants in human diseases | TopicSem |
06 | The summary of TCGA clinical data | MAInfo | ||
09 | The review of the human disease using network biology | xMutant | ||
18 | Research for investigating genomic characteristics in human disease network | TopicSem |
06 | Research for investigating characteristics of genome by human disease | TopicSem | ||
09 | An Ensemble Based Top Performing Approach for NCI-DREAM Drug Sensitivity Prediction Challenge | J.Club |
07 | The analysis for association between gene and classified diseases | TopicSem | ||
14 | NCI-DREAM drug sensitivity prediction challenge | xMutant | ||
18 | Exome-sequence analysis of COAD in TCGA | MAInfo |
04 | Cancer genome database: COSMIC | MAInfo |
01 | The review of variant analysis tool, Sequence To Medical Phenotypes | xMutant | ||
16 | Characteristics of human genes using ppi information | TopicSem |
16 | The correlation between function of genes and variants | TopicSem | ||
21 | Sequence to Medical Phenotypes: A Framework for Interpretation of Human Whole Genome DNA Sequence Data | J.Club |
07 | The complementary interpretations between two pathway groups | TopicSem | ||
27 | The correlation between function of genes and variants in 1KP | xMutant |
15 | Relationships of variants through PPI in 1kp data | xMutant |
15 | Results of the properties of biological network using protein interaction | TopicSem |
15 | The workflow of WXS SG20 analysis | TopicSem |
11 | The workflow of WXS GS20 analysis | TopicSem | ||
23 | Large scale exploration and analysis of drug combinations | J.Club |
08 | The results of pathway analysis using protein domain | TopicSem |
10 | The role of the interactome in the maintenance of deleterious variability in human populations | J.Club | ||
21 | The comparison of the feature in biological network | TopicSem | ||
26 | SG19 | Seminar |
12 | The progress of comparison the feature of two groups in biological network | xMutant | ||
17 | The progress of comparison the feature of two groups in biological network | TopicSem |
16 | KEGG Pathway data download using rest API | xMutant |
01 | The arrangement to extract environmental factors from PubMed articles | TopicSem | ||
05 | Factors extraction for etiome replications | SysBiol |
09 | Protein domain compositions in biological networks | TopicSem |
15 | Biological Process Linkage Networks | J.Club | ||
17 | Domain-Domain interactions in KEGG pathways | TopicSem |
07 | ArrayExpress down | xMutant | ||
25 | Extending pathways based on gene lists using InterPro domain signatures | J.Club |
04 | Enrichment study with data | SysBiol | ||
09 | GEO and How to handle GDS file | xMutant | ||
11 | GSEA & MEA | SysBiol | ||
16 | xMutant | |||
18 | Analysis & KGML | SysBiol | ||
25 | Network Analysis | SysBiol |
04 | trends in biolpgical pathway-based in analysis | Seminar | ||
15 | Enrichment Analysis | SysBiol | ||
21 | advanced Enrichment Analysis | SysBiol | ||
28 | statistics | SysBiol |
30 | Trends in Biological Pathway-based Analysis | Seminar |